Mechanisms of neuroblastoma regression

Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo

(2015) Zaowen Chen et al.   NEOPLASIA

EZH2 as a potential target in cancer therapy

(2014) Michael T McCabe et al.   Epigenomics

Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

(2013) E. Barbieri et al.   CANCER RESEARCH

Insights into neural crest development and evolution from genomic analysis

(2013) M. Simoes-Costa et al.   GENOME RESEARCH

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

(2013) Susan G Kreissman et al.   LANCET ONCOLOGY

Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

(2013) Gemma Gatta et al.   LANCET ONCOLOGY

The genetic landscape of high-risk neuroblastoma

(2013) Trevor J Pugh et al.   NATURE GENETICS

Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics

(2013) N.V. Batora et al.   NEUROSCIENCE

Distinct Neuroblastoma-associated Alterations of PHOX2B Impair Sympathetic Neuronal Differentiation in Zebrafish Models

(2013) Desheng Pei et al.   PLoS Genetics

A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants

(2012) Jed G. Nuchtern et al.   ANNALS OF SURGERY

DNA methylation inhibitors in cancer: Recent and future approaches

(2012) Christina Gros et al.   BIOCHIMIE

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

(2012) G Schleiermacher et al.   BRITISH JOURNAL OF CANCER

The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

(2012) Teeara Berry et al.   CANCER CELL

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity

(2012) K. R. Bosse et al.   CANCER RESEARCH

Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma

(2012) Nai-Kong V. Cheung   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

(2012) Shahab Asgharzadeh et al.   JOURNAL OF CLINICAL ONCOLOGY

Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest

(2012) Max M van Noesel   LANCET ONCOLOGY

Resolved and open issues in chromaffin cell development

(2012) Klaus Unsicker et al.   MECHANISMS OF DEVELOPMENT

Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant

(2012) M. Samy et al.   MOLECULAR CANCER THERAPEUTICS

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

(2012) Jan J. Molenaar et al.   NATURE

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

(2012) Sharon J Diskin et al.   NATURE GENETICS

LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

(2012) Jan J Molenaar et al.   NATURE GENETICS

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

(2012) Mark Sausen et al.   NATURE GENETICS

Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice

(2012) L. C. Heukamp et al.   Science Translational Medicine

Neonatal neuroblastoma

(2012) Jonathan P.H. Fisher et al.   Seminars in Fetal & Neonatal Medicine

Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma

(2012) Denis Andrew Cozzi et al.   WORLD JOURNAL OF SURGERY

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

(2011) C. U. Louis et al.   BLOOD

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

(2011) Jane E. Minturn et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The effect of P75 on Trk receptors in neuroblastomas

(2011) Ruth Ho et al.   CANCER LETTERS

Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

(2011) Anneleen Decock et al.   Epigenetics

Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age

(2011) Denah R. Taggart et al.   JOURNAL OF CLINICAL ONCOLOGY

Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma

(2011) Fang Yu et al.   JOURNAL OF PEDIATRIC SURGERY

Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

(2011) E E Santo et al.   ONCOGENE

Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci

(2011) Lễ B. Nguyễn et al.   PLoS Genetics

Assembling Neural Crest Regulatory Circuits into a Gene Regulatory Network

(2010) Paola Betancur et al.   Annual Review of Cell and Developmental Biology

Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma

(2010) R. Iyer et al.   CLINICAL CANCER RESEARCH

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients

(2010) E. Grau et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

(2010) Malcolm A. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report

(2010) Maryam Fouladi et al.   JOURNAL OF CLINICAL ONCOLOGY

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

(2010) Kai Wang et al.   NATURE

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

(2010) David L. Baker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dependence receptors: a new paradigm in cell signaling and cancer therapy

(2010) D Goldschneider et al.   ONCOGENE

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

(2009) Cinzia Lavarino et al.   BMC CANCER

On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

(2009) C. J. Thiele et al.   CLINICAL CANCER RESEARCH

Trk Receptor Expression and Inhibition in Neuroblastomas

(2009) G. M. Brodeur et al.   CLINICAL CANCER RESEARCH

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

(2009) R. Salcedo et al.   JOURNAL OF IMMUNOLOGY

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

(2009) Mario Capasso et al.   NATURE GENETICS

Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97

(2008) Barbara Hero et al.   JOURNAL OF CLINICAL ONCOLOGY

The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

(2008) Tom Monclair et al.   JOURNAL OF CLINICAL ONCOLOGY

MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

(2008) Jean Bénard et al.   Molecular Oncology

Identification of ALK as a major familial neuroblastoma predisposition gene

(2008) Yaël P. Mossé et al.   NATURE

Activating mutations in ALK provide a therapeutic target in neuroblastoma

(2008) Rani E. George et al.   NATURE

Oncogenic mutations of ALK kinase in neuroblastoma

(2008) Yuyan Chen et al.   NATURE

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

(2008) Isabelle Janoueix-Lerosey et al.   NATURE